methods and compositions for the treatment of crisis-related disorders
CA2994873A1
Amantadine compositions and methods of use
WO2010062996A2
Ribavirin composition
WO2010044929A2
Emergency preparations for an epidemic
WO2009091932A2
Treatment of mild dementia of the alzheimer's disease type
US2008227743A1
Compositions and kits for treating influenza
HK1103517A1
Pharmaceutical composition comprising memantine in an extended dosage release form for use in the treatment of dementias
AU2007203426A1
Methods for treating neuropsychiatric disorders with NMDA receptor antagonists
AU2007254215A1
Methods and compositions for the treatment of viral infections
KR20070116996A
Methods and compositions for treatment of cns disorders
SG157415A1
Composition comprising a sustained release coating or matrix and an nmda receptor antagonist, method for administration such nmda antagonist to a subject
US2006142398A1
Method and composition for administering an NMDA receptor antagonist to a subject
AU2005215767A1
Combination of an NMDA receptor antagonist and an anti-epileptic drug for the treatment of epilepsy and other CNS disorders
